Updates in Cardiac Amyloidosis 2023 | Livestream
The Institute for Future Health is hosting a hybrid (in-person and Livestream) conference on January 14th, 2023, focused on building the knowledge of cardiac amyloidosis amongst Arizona clinicians. This event will be one of the first exclusively dedicated to cardiac amyloidosis. Cardiac amyloidosis is a disease of protein misfolding that leads to congestive heart disease, disabling neuropathy, and other systemic conditions. Cardiac amyloidosis can be caused by transthyretin or light-chain amyloidosis. The pace of knowledge in this field is greatly accelerating, and it is important for clinicians and scientists to be aware of new developments.
Register for this FREE event now: https://theifh.org/amyloidosis
*This activity is supported by an independent medical educational grant from Pfizer, Inc.
The Institute for Future Health (IFH)
LinkedIn: https://www.linkedin.com/company/theifh/
-
Category
No comments found